RxDoctor Payments Data

Howard Pickett, MD

Family Medicine · Excelsior Springs, MONPI 1821069790

Payments from drug & device makers

$7,644in general payments, 2019–2025

Across 440 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$740
  • AstraZeneca$561
  • Otsuka America Pharmaceutical, Inc.$554
  • Amgen$550
  • Pfizer$443
  • plus $3K from 33 others

What the payments were for

  • Food & beverage$7,56999%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,644 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$7,095
Medicare patients
44
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban184$147,388
OzempicSemaglutide128$146,199
MounjaroTirzepatide37$55,344
JardianceEmpagliflozin87$52,136
Trelegy ElliptaFluticasone/Umeclidin/Vilanter64$48,084
RexultiBrexpiprazole30$21,978
VraylarCariprazine Hcl13$21,825
GemtesaVibegron34$17,252
ArexvyRsvpref3 Antigen/As01e/Pf60$15,867
Spiriva RespimatTiotropium Bromide16$14,753
MyrbetriqMirabegron21$11,440
Humalog Kwikpen U-100Insulin Lispro36$9,882
Spiriva HandihalerTiotropium Bromide17$9,852
Incruse ElliptaUmeclidinium Bromide20$9,550
Fluticasone-SalmeterolFluticasone Propion/Salmeterol39$7,952

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$443$152,885205 claims
Novo NordiskOzempic$368$146,199128 claims
GSKTrelegy Ellipta, Arexvy, Incruse Ellipta, Breo Ellipta$285$79,110155 claims
Boehringer IngelheimJardiance, Spiriva Respimat$238$66,889103 claims
Lilly USA, LLCMounjaro, Humalog$740$58,61168 claims
Otsuka America Pharmaceutical, Inc.Rexulti$554$21,97830 claims
AbbVieVraylar$1,493$21,82513 claims
Sumitomo Pharma America, Inc.Gemtesa$114$17,25234 claims
Astellas Pharma US IncMyrbetriq$254$11,44021 claims
AstraZenecaSymbicort$561$7,46128 claims
MerckDulera$112$5,39015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Excelsior Springs

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →